Effect of "HAART" on CD4+ T lymphocyte counts in HIV seropositive south-Indian individuals--a follow up study
Shahapur, P.R.; Bairy, I.; Shivananda, P.G.
Indian Journal of Pathology and Microbiology 48(2): 270-272
2005
ISSN/ISBN: 0377-4929 PMID: 16758693 Document Number: 592504
Because of the drastic cut down in the prices of antiretroviral drugs, the antiretroviral therapy has become more affordable in India. 16 HIV-1 infected individuals who were on HAART were followed up for 12 months. The CD4 + T Cell count estimation was done at mean intervals of 6 months and 12 months. Antiretroviral therapy showed good response in 14(87.5%) and deterioration in 2 (12.5%) cases.
Document emailed within 1 workday
Related Documents
Kannangai, R.; Ramalingam, S.; Vijayakumar, T.S.; Vincent, A.A.; Abraham, O.C.; Subramanian, S.; Rupali, P.; Mathai, D.; Jesudason, M.V.; Sridharan, G. 2003: The immunological and virological response in human immunodeficiency virus type-1 (HIV-1) infected Indian individuals on HAART therapy: a one-year follow up study Indian Journal of Medical Microbiology 21(4): 274-276Xie, J.; Qiu, Z.; Han, Y.; Li, Y.; Song, X.; Li, T. 2015: A multicenter study of correlation between peripheral lymphocyte counts and CD(+)4T cell counts in HIV/AIDS patients Zhonghua Nei Ke Za Zhi 54(2): 118-121
Sobti, R.Chander.; Berhane, N.; Mehedi, S.Abedule.; Kler, R.; Hosseini, S.Ali.; Kuttiat, V.; Wanchu, A. 2010: Association and impact of XPG Asp 1104 His gene polymorphism in HIV 1 disease progression to AIDS among north Indian HIV seropositive individuals Molecular Biology Reports 37(1): 317-324
Sud, N.; Shanker, V.; Sharma, A.; Sharma, N.L.; Gupta, M. 2009: Mucocutaneous manifestations in 150 HIV-infected Indian patients and their relationship with CD4 lymphocyte counts International Journal of Std and Aids 20(11): 771-774
Nagmoti, M.B.; Patil, C.S.; Jyoti, M.N.; Mutnal, M.B.; Mallapur, M.D. 2012: Prevalence of hepatitis C infection in HIV-seropositive individuals in and around Belgaum, south India International Journal of Std and Aids 23(10): E14-E15
Venkataramani, A.S.; Maughan-Brown, B.; Nattrass, N.; Ruger, J.P. 2010: Social grants, welfare, and the incentive to trade-off health for income among individuals on HAART in South Africa Aids and Behavior 14(6): 1393-1400
Valdimarsson, H.; Mulholland, C.; Fridriksdottir, V.; Coleman, D.V. 1983: A longitudinal study of leucocyte blood counts and lymphocyte responses in pregnancy: a marked early increase of monocyte-lymphocyte ratio Clinical and Experimental Immunology 53(2): 437-443
Venkatesh, K.K.; Srikrishnan, A.K.; Safren, S.A.; Triche, E.W.; Thamburaj, E.; Prasad, L.; Lurie, M.N.; Kumar, M.Suresh.; Kumarasamy, N.; Solomon, S.; Mayer, K.H. 2011: Sexual risk behaviors among HIV-infected South Indian couples in the HAART era: implications for reproductive health and HIV care delivery Aids Care 23(6): 722-733
Sinha, S.; Satishchandra, P. 2003: Nervous system involvement in asymptomatic HIV seropositive individuals: a cognitive and electrophysiological study Neurology India 51(4): 466-469
Shah, I.; Katira, B. 2009: Tuberculosis co-infection in HAART naive HIV infected children - an Indian study Indian Journal of Pediatrics 76(9): 966-967
Tornero, C.; Gimeno, Cón.; Igual, R.; Santamaría, A.; Gil, E.; Rull, S. 2003: Effect of HAART on HCV viral load in the first three years of follow-up Medicina clinica 121(11): 408-409
Bass, H.Z.; Hardy, W.D.; Mitsuyasu, R.T.; Taylor, J.M.; Wang, Y.X.; Fischl, M.A.; Spector, S.A.; Richman, D.D.; Fahey, J.L. 1992: The effect of zidovudine treatment on serum neopterin and beta 2-microglobulin levels in mildly symptomatic, HIV type 1 seropositive individuals Journal of Acquired Immune Deficiency Syndromes 5(3): 215-221
Zukowska-Szczechowska, E. 1984: Effect of dialysis therapy on the T, EAC+ and E--EAC--lymphocyte counts. I. Chronic renal failure Acta Medica Polona 25(1-4): 45-62
Chaudhury, A.; Rajasekhar, D.; Latheef, S.A.A.; Subramanyam, G. 2003: Seropositivity of Chlamydia pneumoniae and Helicobacter pylori among coronary heart disease patients and normal individuals in a South Indian population Indian Heart Journal 55(4): 384
Djarma, O.ïm.; Nguyen, Y.; Renois, F.; Djimassal, A.; Banisadr, F.; Andreoletti, L. 2014: Continuous free access to HAART could be one of the potential factors impacting on loss to follow-up in HAART-eligible patients living in a resource-limited setting: N'djamena, Chad Transactions of the Royal Society of Tropical Medicine and Hygiene 108(11): 735-738
Ramana, K.V.; Sabitha, V.; Rao, R. 2013: A Study of Alternate Biomarkers in HIV Disease and Evaluating their Efficacy in Predicting T CD4+ Cell Counts and Disease Progression in Resource Poor Settings in Highly Active Antiretroviral Therapy (HAART) Era Journal of Clinical and Diagnostic Research: Jcdr 7(7): 1332-1335
Sandström, E.; Urassa, W.; Bakari, M.; Swai, A.; Mhalu, F.; Biberfeld, G.; Pallangyo, K. 2003: Estimation of CD4 T-lymphocyte counts from percent CD4 T-lymphocyte determinations in HIV-1-infected subjects in sub-Saharan Africa International Journal of Std and Aids 14(8): 547-551
Ullum, H.; Palmø, J.; Halkjaer-Kristensen, J.; Diamant, M.; Klokker, M.; Kruuse, A.; LaPerriere, A.; Pedersen, B.K. 1994: The effect of acute exercise on lymphocyte subsets, natural killer cells, proliferative responses, and cytokines in HIV-seropositive persons Journal of Acquired Immune Deficiency Syndromes 7(11): 1122-1133
Jäntti, J.; Kaarela, K.; Kautiainen, H.; Isomäki, H.; Aho, K. 2001: Radiographic remission in seropositive rheumatoid arthritis. a 20-year follow-up study Clinical and Experimental Rheumatology 19(5): 573-576
d'Arminio Monforte, A.; Testori, V.; Adorni, F.; Castelnuovo, B.; Bini, T.; Testa, L.; Moscatelli, G.; Chiesa, E.; Rusconi, S.; Abeli, C.; Sollima, S.; Musicco, M.; Meroni, L.; Galli, M.; Moroni, M. 1999: CD4 cell counts at the third month of HAART may predict clinical failure Aids 13(13): 1669-1676